In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon β-1a differed from standard care for in-hospital mortality.
Identifieur interne : 000410 ( Main/Corpus ); précédent : 000409; suivant : 000411In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon β-1a differed from standard care for in-hospital mortality.
Auteurs : Raina Zhang ; Eleftherios MylonakisSource :
- Annals of internal medicine [ 1539-3704 ] ; 2021.
English descriptors
- KwdEn :
- Adenosine Monophosphate (analogs & derivatives), Adenosine Monophosphate (therapeutic use), Aged (MeSH), Alanine (analogs & derivatives), Alanine (therapeutic use), Antiviral Agents (therapeutic use), COVID-19 (drug therapy), COVID-19 (mortality), Drug Therapy, Combination (MeSH), Female (MeSH), Hospital Mortality (MeSH), Hospitalization (MeSH), Humans (MeSH), Hydroxychloroquine (therapeutic use), Intention to Treat Analysis (MeSH), Interferon beta-1a (therapeutic use), Kaplan-Meier Estimate (MeSH), Length of Stay (MeSH), Lopinavir (therapeutic use), Male (MeSH), Middle Aged (MeSH), Multicenter Studies as Topic (MeSH), Randomized Controlled Trials as Topic (MeSH), Respiration, Artificial (MeSH), Treatment Failure (MeSH), World Health Organization (MeSH).
- MESH :
- chemical , analogs & derivatives : Adenosine Monophosphate, Alanine.
- chemical , therapeutic use : Adenosine Monophosphate, Alanine, Antiviral Agents, Hydroxychloroquine, Interferon beta-1a, Lopinavir.
- drug therapy : COVID-19.
- mortality : COVID-19.
- Aged, Drug Therapy, Combination, Female, Hospital Mortality, Hospitalization, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Length of Stay, Male, Middle Aged, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Respiration, Artificial, Treatment Failure, World Health Organization.
Abstract
SOURCE CITATION
Pan H, Peto R, Henao-Restrepo AM, et al.
DOI: 10.7326/ACPJ202102160-017
PubMed: 33524282
Links to Exploration step
pubmed:33524282Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon β-1a differed from standard care for in-hospital mortality.</title><author><name sortKey="Zhang, Raina" sort="Zhang, Raina" uniqKey="Zhang R" first="Raina" last="Zhang">Raina Zhang</name><affiliation><nlm:affiliation>Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA (R.Z., E.M.).</nlm:affiliation></affiliation></author><author><name sortKey="Mylonakis, Eleftherios" sort="Mylonakis, Eleftherios" uniqKey="Mylonakis E" first="Eleftherios" last="Mylonakis">Eleftherios Mylonakis</name><affiliation><nlm:affiliation>Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA (R.Z., E.M.).</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2021">2021</date><idno type="RBID">pubmed:33524282</idno><idno type="pmid">33524282</idno><idno type="doi">10.7326/ACPJ202102160-017</idno><idno type="wicri:Area/Main/Corpus">000410</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000410</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon β-1a differed from standard care for in-hospital mortality.</title><author><name sortKey="Zhang, Raina" sort="Zhang, Raina" uniqKey="Zhang R" first="Raina" last="Zhang">Raina Zhang</name><affiliation><nlm:affiliation>Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA (R.Z., E.M.).</nlm:affiliation></affiliation></author><author><name sortKey="Mylonakis, Eleftherios" sort="Mylonakis, Eleftherios" uniqKey="Mylonakis E" first="Eleftherios" last="Mylonakis">Eleftherios Mylonakis</name><affiliation><nlm:affiliation>Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA (R.Z., E.M.).</nlm:affiliation></affiliation></author></analytic><series><title level="j">Annals of internal medicine</title><idno type="eISSN">1539-3704</idno><imprint><date when="2021" type="published">2021</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenosine Monophosphate (analogs & derivatives)</term><term>Adenosine Monophosphate (therapeutic use)</term><term>Aged (MeSH)</term><term>Alanine (analogs & derivatives)</term><term>Alanine (therapeutic use)</term><term>Antiviral Agents (therapeutic use)</term><term>COVID-19 (drug therapy)</term><term>COVID-19 (mortality)</term><term>Drug Therapy, Combination (MeSH)</term><term>Female (MeSH)</term><term>Hospital Mortality (MeSH)</term><term>Hospitalization (MeSH)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (therapeutic use)</term><term>Intention to Treat Analysis (MeSH)</term><term>Interferon beta-1a (therapeutic use)</term><term>Kaplan-Meier Estimate (MeSH)</term><term>Length of Stay (MeSH)</term><term>Lopinavir (therapeutic use)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Multicenter Studies as Topic (MeSH)</term><term>Randomized Controlled Trials as Topic (MeSH)</term><term>Respiration, Artificial (MeSH)</term><term>Treatment Failure (MeSH)</term><term>World Health Organization (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Adenosine Monophosphate</term><term>Alanine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adenosine Monophosphate</term><term>Alanine</term><term>Antiviral Agents</term><term>Hydroxychloroquine</term><term>Interferon beta-1a</term><term>Lopinavir</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>COVID-19</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Drug Therapy, Combination</term><term>Female</term><term>Hospital Mortality</term><term>Hospitalization</term><term>Humans</term><term>Intention to Treat Analysis</term><term>Kaplan-Meier Estimate</term><term>Length of Stay</term><term>Male</term><term>Middle Aged</term><term>Multicenter Studies as Topic</term><term>Randomized Controlled Trials as Topic</term><term>Respiration, Artificial</term><term>Treatment Failure</term><term>World Health Organization</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>SOURCE CITATION</b></p><p>Pan H, Peto R, Henao-Restrepo AM, et al. </p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33524282</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1539-3704</ISSN><JournalIssue CitedMedium="Internet"><Volume>174</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>02</Month></PubDate></JournalIssue><Title>Annals of internal medicine</Title><ISOAbbreviation>Ann Intern Med</ISOAbbreviation></Journal><ArticleTitle>In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon β-1a differed from standard care for in-hospital mortality.</ArticleTitle><Pagination><MedlinePgn>JC17</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7326/ACPJ202102160-017</ELocationID><Abstract><AbstractText Label="SOURCE CITATION">Pan H, Peto R, Henao-Restrepo AM, et al. <b>Repurposed antiviral drugs for Covid-19-interim WHO Solidarity Trial results.</b> N Engl J Med. 2020. [Epub ahead of print.] 33264556.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Raina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA (R.Z., E.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mylonakis</LastName><ForeName>Eleftherios</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA (R.Z., E.M.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Intern Med</MedlineTA><NlmUniqueID>0372351</NlmUniqueID><ISSNLinking>0003-4819</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>2494G1JF75</RegistryNumber><NameOfSubstance UI="D061466">Lopinavir</NameOfSubstance></Chemical><Chemical><RegistryNumber>3QKI37EEHE</RegistryNumber><NameOfSubstance UI="C000606551">remdesivir</NameOfSubstance></Chemical><Chemical><RegistryNumber>415SHH325A</RegistryNumber><NameOfSubstance UI="D000249">Adenosine Monophosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>OF5P57N2ZX</RegistryNumber><NameOfSubstance UI="D000409">Alanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>XRO4566Q4R</RegistryNumber><NameOfSubstance UI="D000068556">Interferon beta-1a</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000249" MajorTopicYN="N">Adenosine Monophosphate</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057194" MajorTopicYN="N">Intention to Treat Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068556" MajorTopicYN="N">Interferon beta-1a</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061466" MajorTopicYN="N">Lopinavir</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>1</Day><Hour>20</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33524282</ArticleId><ArticleId IdType="doi">10.7326/ACPJ202102160-017</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000410 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000410 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:33524282
|texte= In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon β-1a differed from standard care for in-hospital mortality.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:33524282" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |